Tarsus Pharmaceuticals Inc. monthly returns
Tarsus Pharmaceuticals Inc. has averaged 2.01% per month, positive in 51% of months. Month-by-month returns for Tarsus Pharmaceuticals Inc. (TARS) below, through October 20, 2026 — the table lists the most recent months; the bar chart plots the last 5 years.
Tarsus Pharmaceuticals Inc. monthly returns#
| Month | Path | Total return |
|---|---|---|
| Oct 2026 | -9.6% | |
| Sep 2026 | +5.9% | |
| Aug 2026 | +25.7% | |
| Jul 2026 | -6.2% | |
| Jun 2026 | +6.0% | |
| May 2026 | -6.6% | |
| Apr 2026 | -9.3% | |
| Mar 2026 | -7.1% | |
| Feb 2026 | +17.0% | |
| Jan 2026 | -21.2% | |
| Dec 2025 | +2.4% | |
| Nov 2025 | +16.2% | |
| Oct 2025 | +15.8% | |
| Sep 2025 | +1.5% | |
| Aug 2025 | +50.9% | |
| Jul 2025 | -4.2% | |
| Jun 2025 | -5.7% | |
| May 2025 | -17.3% | |
| Apr 2025 | +1.1% | |
| Mar 2025 | +15.5% | |
| Feb 2025 | -17.3% | |
| Jan 2025 | -2.9% | |
| Dec 2024 | +5.6% | |
| Nov 2024 | +17.9% | |
| Oct 2024 | +35.3% | |
| Sep 2024 | +21.3% | |
| Aug 2024 | +11.6% | |
| Jul 2024 | -10.6% | |
| Jun 2024 | -17.5% | |
| May 2024 | +4.9% | |
| Apr 2024 | -13.5% | |
| Mar 2024 | -4.9% | |
| Feb 2024 | +40.3% | |
| Jan 2024 | +34.5% | |
| Dec 2023 | +22.5% | |
| Nov 2023 | +16.1% | |
| Oct 2023 | -19.9% | |
| Sep 2023 | +1.5% | |
| Aug 2023 | -20.4% | |
| Jul 2023 | +21.8% | |
| Jun 2023 | +7.9% | |
| May 2023 | +12.3% | |
| Apr 2023 | +18.7% | |
| Mar 2023 | -18.9% | |
| Feb 2023 | -1.7% | |
| Jan 2023 | +7.5% | |
| Dec 2022 | -12.8% | |
| Nov 2022 | -8.7% | |
| Oct 2022 | +7.6% | |
| Sep 2022 | +11.3% | |
| Aug 2022 | +2.4% | |
| Jul 2022 | +2.9% | |
| Jun 2022 | +6.2% | |
| May 2022 | -24.9% | |
| Apr 2022 | +8.9% | |
| Mar 2022 | -4.6% | |
| Feb 2022 | -12.2% | |
| Jan 2022 | -10.8% | |
| Dec 2021 | -15.4% | |
| Nov 2021 | -4.2% | |
| Oct 2021 | +28.8% | |
| Sep 2021 | -18.7% | |
| Aug 2021 | +17.4% | |
| Jul 2021 | -22.1% | |
| Jun 2021 | -13.0% | |
| May 2021 | +8.5% | |
| Apr 2021 | -4.7% | |
| Mar 2021 | -11.1% | |
| Feb 2021 | -3.8% | |
| Jan 2021 | -8.8% | |
| Dec 2020 | +71.0% | |
| Nov 2020 | +18.2% |
Monthly total return (since Nov 2021)#
Tarsus Pharmaceuticals Inc. returns by calendar month#
Every month of every year since 2021, one tick per year on a shared scale; the dark bar is the month's average. Total returns, dividends reinvested.
October 2026 so far: -9.64% — 5th of 6 Octobers since 2021 at the last close; the average October returned +13.5%.
| Month | −55%0+55% | Average | Median | Up | Best | Worst |
|---|---|---|---|---|---|---|
| Jan | -0.3% | -5.8% | 33% | +34.5% 2024 | -21.2% 2026 | |
| Feb | +3.7% | -2.8% | 33% | +40.3% 2024 | -17.3% 2025 | |
| Mar | -5.2% | -6.0% | 17% | +15.5% 2025 | -18.9% 2023 | |
| Apr | +0.2% | -1.8% | 50% | +18.7% 2023 | -13.5% 2024 | |
| May | -3.9% | -0.9% | 50% | +12.3% 2023 | -24.9% 2022 | |
| Jun | -2.7% | +0.1% | 50% | +7.9% 2023 | -17.5% 2024 | |
| Jul | -3.1% | -5.2% | 33% | +21.8% 2023 | -22.1% 2021 | |
| Aug | +14.6% | +14.5% | 83% | +50.9% 2025 | -20.4% 2023 | |
| Sep | +3.8% | +3.7% | 83% | +21.3% 2024 | -18.7% 2021 | |
| Oct | +13.5% | +15.8% | 80% | +35.3% 2024 | -19.9% 2023 | |
| Nov | +7.5% | +16.1% | 60% | +17.9% 2024 | -8.7% 2022 | |
| Dec | +0.5% | +2.4% | 60% | +22.5% 2023 | -15.4% 2021 |
Methodology#
Monthly returns are total returns (dividends reinvested), computed from TARS's split- and dividend-adjusted month-end closes. The table shows the most recent 120 months and the bar chart the most recent 60. See the year-by-year returns for the annual view. Past performance does not predict future returns; not investment advice.
FAQ#
- What is Tarsus Pharmaceuticals Inc.'s average monthly return?
- Tarsus Pharmaceuticals Inc. (TARS) has averaged about 2.01% per month, positive in roughly 51% of months. The best month was Aug 2025 (+50.9%) and the worst was May 2022 (-24.9%).